| htlv-i and -ii in intravenous drug users from sweden and denmark. | 693 ivdu (intravenous drug user) sera from copenhagen, malmö and stockholm were tested, 247 retro- and 446 prospectively, for antibodies to human t-lymphotropic virus (htlv), types i and ii, by means of a commercial whole-virus eia and/or an htlv-i/-ii peptide-based eia. positive eia reactions were checked and typed by electrophoretic immunoblotting, a differential peptide-based eia and nucleic acid amplification/hybridization with htlv-i and -ii specific primers and probes. 3 (0.7%) of the pros ... | 1994 | 8191236 |
| prevalence and risk factors for htlv-ii infection in 913 injecting drug users in stockholm, 1994. | the prevalence and risk factors for acquisition of human t-cell lymphotropic virus type i and ii (htlv-i and ii) were investigated in a prospective study of 913 injecting drug users (idus) in stockholm in 1994. epidemiologic data were recorded, and blood samples were tested for antibodies against htlv-i and htlv-ii; human immunodeficiency virus (hiv) types 1 and 2; and hepatitis a (hav), b (hbv), c (hcv), and d (hdv). positive serologic results for htlv were confirmed by western blot (wb) and po ... | 1997 | 9342259 |
| htlv-ii among injecting drug users in stockholm. | 134 injecting drug users (idus) treated at the department of infectious diseases of roslagstull hospital, stockholm, were tested for antibodies to human t-lymphotropic virus, types i and ii, by means of 2 htlv-i/-ii peptide-based enzyme immunoassays (eias), followed by a whole-virus eia. positive eia reactions were checked and typed by electrophoretic immunoblotting with native htlv-i and recombinant htlv-i and -ii proteins. 10 idus were diagnosed as htlv-ii seropositive. all 10 were of scandina ... | 1994 | 8036466 |
| htlv infections among swedish intravenous drug users in 1992. | serum samples collected in 1992 from 1158 intravenous drug users (ivdus) in stockholm, sweden, were tested retrospectively for antibodies to human t-lymphotropic virus type i and ii (htlv-i and ii). the overall prevalence rate of htlv infections was 2.4% (28/1158). a majority of the htlv infections were caused by htlv-ii (27/28). a significant association between htlv-ii and hiv-1 seropositivity was found, the prevalence of htlv-ii infection being 11.4% (11/96) in hiv-seropositive individuals co ... | 1995 | 8685631 |
| prevalence of human t-lymphotropic virus type 1 and 2 infection in sweden. | prevalence data on human t-lymphotropic virus types 1 and 2 (htlv-1/2) in sweden have not been updated since 1995. the seroprevalence among blood donors at that time was 0.2/10,000. a few years earlier, a high prevalence of htlv-2 was found in intravenous drug users (idus) in stockholm (3.4%). the objective of this study was to update information on the seroprevalence of htlv in several study groups. | 2012 | 22803699 |